“Proteomics International said Tuesday that it has partnered with Bioplatforms Australia and the Uni...
Proteomics International has formed a partnership with Bioplatforms Australia and the University of ...
Proteomics International raises A$3.0 million via a heavily oversubscribed Placement.
“Proteomics International Laboratories has secured CE Mark registration for its PromarkerD as a diag...
Proteomics International is proud to announce it has secured CE Mark registration for PromarkerD (MS...
The Company announces that its balance sheet has been further strengthened by the receipt of over $1...
“During a gala celebration of Western Australia’s exporters, 18 businesses were recognised for their...
“Proteomics International Laboratories Ltd, a medical technology company headquartered in Perth, Aus...
360Dx — Proteomics International Laboratories Transfers Diabetic Kidney Disease Test Tech to Atturos
“NEW YORK — Proteomics International Laboratories said on Thursday that it has completed the transfe...
Proteomics International announces successful performance validation results for a new advanced Prom...
Proteomics International has officially launched PromarkerD in Spain under a deal with Patia Europe.
PromarkerD was showcased at the 55th Annual Meeting of the European Association for the Study of Dia...
Proteomics International completes technology transfer of PromarkerD to clinical diagnostics partner...
Latest PromarkerD clinical validation results published in the Journal of Diabetes and its Complicat...
Proteomics International attended the 18th Human Proteome Organization World Congress, September 15t...
“The successful TGA approval for PromarkerD software as an IVD forms part of Proteomics Internationa...
Proteomics International is pleased to announce TGA regulatory approval granted for PromarkerD softw...
Proteomics International is pleased to announce that it has secured two new contracts to conduct pha...
Proteomics International presented at the 121 Tech Investment Summit in Hong Kong. The 121 Summit is...
“Proteomics International Laboratories Ltd (ASX:PIQ) has been invited to feature on the American Dia...
Proteomics International was invited to feature on the American Diabetes Association (ADA) TV News N...
Proteomics International showcased PromarkerD at BIO International Convention – Philadelphia, June 3...
“In a world-first, biotech company Proteomics International has discovered a predictive diagnostic t...
Proteomics International has been granted a new patent that has important longer-term potential valu...
Proteomics International rescinds PromarkerD exclusive licence deal with PrismHealthDx in US – negot...
It has taken over 15 years, but Perth-based medical technology company Proteomics International is n...